PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsLeprosy
MeSH D007918 - leprosy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009165:Nontuberculous mycobacterium infections
44 Companies
8 Drugs
$
Success rate
D007918: 
Leprosy
13 Companies
4 Drugs
$
Success rate
D056005:Paucibacillary leprosy
0 Companies
0 Drugs
Success rate
D056006:Multibacillary leprosy
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanRifampin Rifampin  2008-05-22   
Lupin ResearchRifampin Rifampin  2013-08-21   
SanofiRifampin Rifadin  1982-01-01   
Isoniazid, Rifampin Rifamate  1982-01-01   
Isoniazid, Rifampin, Pyrazinamide Rifater  1994-05-31   
Chartwell PharmaceuticalsRifampin Rifampin  2008-03-28   
Hikma PharmaceuticalsRifampin Rifampin  1999-10-29   
Isoniazid, Rifampin Rifampin Isoniazid  2005-07-29   
Epic PharmaRifampin Rifampin  1997-05-28   
Oxford PharmaceuticalsRifampin Rimactane  1982-01-01   
Fresenius KabiRifampin Rifampin  2014-08-21   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
75%
6/8
Phase 3
25%
3/12
Approved: 2Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Rifampin
Sanofi
Isoniazid,
Pyrazinamide,
Rifampin
Bristol Myers Squibb
Thalidomide
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use